期刊文献+

亚临床皮质醇增多症与骨质疏松症的关系:系统综述和meta分析 被引量:9

Relationship between subclinical hypercortisolism and osteoporosis: A systematic review and meta-analysis
原文传递
导出
摘要 目的探讨亚临床皮质醇增多症(SH)与骨质疏松症的关系。方法检索MEDLINE、B10SISPreviews、HighWire、维普数据库、万方数据库获取研究SH与骨质疏松的关系的文献。以骨密度、骨转换生化标志物、骨质疏松症患病率、骨折发病率为结局指标。仅限中英文文献。按照纳入和排除标准选择相关研究进行文献质量评价后,使用RevMan5软件进行meta分析。结果共纳入研究15个,回顾性研究6个,前瞻性研究6个,干预性研究3个。回顾性研究显示骨密度水平在亚临床皮质醇增多症组(SH+组)明显低于非亚临床皮质醇增多症组(SH一组),前瞻性研究meta分析发现腰椎及股骨颈骨密度水平SH+组显著低于SH一组(均P〈0.01),而回顾性研究和前瞻性研究均显示骨转换生化指标在两组问则无显著差异;干预性研究显示对SH的患者进行手术干预不能改善预后。结论SH可以降低腰椎及股骨颈骨密度.增加骨质疏松症患病率及骨折发病率.对并发骨质疏松症的SH的患者进行手术干预.不能明确回答患者是否获益,有待进一步研究。 Objective To explore the relationship between subclinical hypercortisolism ( SH ) and osteoprosis. Methods MEDLINE, BIOSIS Previews, High Wire Wanfang Database, and Vip Database were retrieved for articles about the relations of SH and osteoporosis. Searches were limited to Chinese/English-language publications. The clinical outcomes evaluated in this study included bone mineral density, biochemical markers of bone turnover, prevalence of osteoporosis, and incidence of fracture. Meta-analysis was carried out by RevMan5 among articles suitable for the inclusion and exclusion criteria. Results Fifteen studies were included, containing 6 retrospective studies, 6 prospective studies, and 3 intervention studies. Retrospective studies suggested that bone mineral density level in subclinical hypercortisolism group ( SH + group ) was significantly lower than that in the nonsubclinical hypercortisolism group ( SH- group) , meta-analysis of prospective studies showed that the level of bone mineral density at lumbar spine and femoral neck was significantly lower in SH+ group than that in the SH- group( all P〈0.01 ). Both retrospective studies and prospective studies showed no significant difference between the biochemical markers of bone turnover in both SH+ and SH- groups. Data from intervention studies showed that the prognosis in SH patients with surgical intervention was not improved. Conclusions SH reduces bone mineral density at lumbar spine and femoral neck, and increases the prevalence of osteoporosis and incidence of fracture. Whether surgical intervention is beneficial in SH patients remains uncertain.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2013年第6期460-465,共6页 Chinese Journal of Endocrinology and Metabolism
关键词 骨质疏松症 皮质醇增多症 骨密度 META分析 Osteoporosis Hypercortisolism Bone mineral density Meta-analysis
  • 相关文献

参考文献31

  • 1Arnaldi G, Angeli A, Atkinson AB, et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Fndocrinol Metab, 2003,88 :5593-5602.
  • 2Shaker JL, Lukert BP.Osteoporosis associated with excess glucocorticoids. Endocrinol Metab Clin North Am, 2005, 34: 341- 356.
  • 3van Staa TP, Lcufkcns HC, Cooper C. The epidemiology of corticosteroid-induced Osteoporosis: a meta analysis. Osteoporosis Int. 2002,13 :777-787.
  • 4Chiodini I, Mascia ML, Muscarella S, et al. Subclinical hypercortisolism among outpatients referred for osteoporosis. Ann Intern Med, 2007,147 :541-548.
  • 5Manero F, Masini AM, Opocher G, et al. Adrenal incidentaloma , an overview of hormonal data from the National Italian Study Group. Horm Res, 1997,47 :284-289.
  • 6Mantero F, Terzolo M, Araldi G, et al. A survey on adrenal incidentalomas in Italy: Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab, 2000,85: 637- 644.
  • 7Rossi R, Tauchmanova L, Luciano A, et al. Subclinical Cushing's syndrome in patients adrenal incidentaloma Clinical and biochemical features. J Clin Endocrinol Metab, 2000,85 : 1440-1448.
  • 8Morelli V, Masserini B, Salcuni AS, et al. Subclinical hvpen-or?tisolism , correlation between biochemical diagnosic criteria and clinical aspects. Clin Endocrinol, 2010,73: 161-166.
  • 9Pittas AG, Chung M, Trikalinos T , et al. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med, 2010,152 :307-314.
  • 10Sartorio A, Conti A, Ferrero S, et al. Evaluation of bone collagen turnover in patients with active and preclinical Cushing's syndrome and in patients with adrenal incidentalomas. Eur J Endoerinol, 1998, 138 : 146-152.

同被引文献62

  • 1薛延.骨质疏松症的现状、流行趋势与研究方向[J].中国全科医学,2005,8(16):1299-1299. 被引量:26
  • 2原发性骨质疏松症诊疗指南(讨论稿)[J].中华全科医师杂志,2006,5(8):455-457. 被引量:66
  • 3傅红,高敏侃,曲兴龙,孙国防,沈磊.完全性胸腹腔内脏反位合并十二指肠壶腹周围癌一例报告与文献复习[J].中华胃肠外科杂志,2007,10(2):134-137. 被引量:10
  • 4冬梅,毕力夫,苏秀兰.瘦素与骨质疏松症研究现状[J].中国骨质疏松杂志,2007,13(10):739-742. 被引量:8
  • 5Dekkers OM, Biermasz NR, Pereira AM, et al.Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma [J]. J Clin Endocrinol Metab, 2007,92(3 ) : 976-981.
  • 6刘嫒,王永福,刘忠厚.骨质疏松诊断[M].北京:中国现代文艺出版社,2011:218-221.
  • 7Hayakawa N,Suzuki A. Secondary Osteoporosis or Secondary Contributors to Bone Loss in Fracture.Therapeutic strategy for glucocorticoidinduced osteoporosis[J].Clin Calcium,2013,(09):1337-1344.
  • 8Asano S,Suzuki A. Assessment of the treatment of glucocorticoid-induced osteoporosis[J].Clin Calcium,2013,(03):401-408.
  • 9Ringe JD,Schacht E,Dukas L. Potency of a combined alfacalcidol-alendronate therapy to reduce the risk of falls and fractures in elderly patients with glucocorticoid-induced osteoporosis[J].{H}Arzneimittel-Forschung,2011,(02):104-111.
  • 10Takeda S,Kaneoka H,Saito T. Effect of alendronate on glucocorticoidinduced osteoporosis in Japanese women with systemic autoimmune diseases:versus lfacalcidol[J].{H}MODERN RHEUMATOLOGY,2008,(03):271-276.

引证文献9

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部